Joel M. Gelfand, MD, MSCE, FAAD
Dermatology
Accepting new patients
Sees patients age 4 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737
Headshot of Joel M. Gelfand, MD, MSCE, FAAD
Penn Medicine Provider

About me

  • Director, Psoriasis and Phototherapy Treatment Center
  • Director, Center for Clinical Sciences in Dermatology
  • James J. Leyden, M.D. Endowed Professor in Clinical Investigation
  • Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: Harvard University
  • Residency: Mount Sinai Hospital
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

383 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
February 2026
focused, patient centered and world class
Anonymous
February 2026
he is a great provider.
Anonymous
February 2026
was seen quickly
Anonymous
January 2026
thorough, not rushed, answered all questions

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Gelfand is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, Gelfand JM Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis , J Am Acad Dermatol, 68(1): 2013,64-72

Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, Alavi A Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) , J Vis Exp, 63: 2012,e3777

Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis , Arch Dermatol, 148(9): 2012,995-1000

Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting , Arch Dermatol, 148(4): 2012,487-94

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom , J Invest Dermatol, 132(3Pt1): 2012,556-62

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study , Arch Dermatol, 147(9): 2011,1031-9

Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, Gelfand JM. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials , J Am Acad Dermatol, 64(6): 2011,1035-50

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database , Eur Heart J, 31(8): 2010,1000-6

Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB The risk of stroke in patients with psoriasis , J Invest Determatol, 129(10): 2009,2411-8

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB The risk of lymphoma in patients with psoriasis , J Invest Dermatol, 126(10): 2006,2194-201